State Street’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,916,781
Closed -$470K 4359
2024
Q4
$470K Buy
3,916,781
+406,900
+12% +$51.2K ﹤0.01% 3635
2024
Q3
$482K Hold
3,509,881
﹤0.01% 3606
2024
Q2
$513K Buy
3,509,881
+399,300
+13% +$59.8K ﹤0.01% 3563
2024
Q1
$454K Sell
3,110,581
-211,100
-6% -$29.5K ﹤0.01% 3673
2023
Q4
$665K Hold
3,321,681
﹤0.01% 3576
2023
Q3
$555K Hold
3,321,681
﹤0.01% 3644
2023
Q2
$664K Hold
3,321,681
﹤0.01% 3636
2023
Q1
$703K Sell
3,321,681
-16,700
-0.5% -$4.09K ﹤0.01% 3637
2022
Q4
$544K Hold
3,338,381
﹤0.01% 3745
2022
Q3
$704K Hold
3,338,381
﹤0.01% 3667
2022
Q2
$735K Sell
3,338,381
-15,379,313
-82% -$3.92M ﹤0.01% 3701
2022
Q1
$6.31M Sell
18,717,694
-10,012,508
-35% -$3.28M ﹤0.01% 3067
2021
Q4
$8.81M Buy
28,730,202
+5,932,371
+26% +$2.67M ﹤0.01% 2984
2021
Q3
$11.9M Buy
22,797,831
+4,431,423
+24% +$2.61M ﹤0.01% 2784
2021
Q2
$15.3M Buy
18,366,408
+12,993,071
+242% +$12.1M ﹤0.01% 2663
2021
Q1
$8.49M Buy
+5,373,337
New +$8.78M ﹤0.01% 2816
2019
Q2
Sell
-448,805
Closed -$157K 3868
2019
Q1
$157K Buy
448,805
+3,100
+0.7% +$2.73K ﹤0.01% 3595
2018
Q4
$548K Buy
+445,705
New +$706K ﹤0.01% 3432
2018
Q3
Sell
-299,000
Closed -$672K 3820
2018
Q2
$672K Buy
+299,000
New +$600K ﹤0.01% 3443

Other funds holding ZOM

State Street's ZOM Position: Q1 2025 in Review

State Street sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 3,916,781 shares — an estimated $470K sold.

State Street first reported a position in ZOM in Q2 2018 and held it in 19 quarters. The position peaked at $15.3M in Q2 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • State Street reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • State Street sold 3,916,781 Zomedica Corp. shares in Q1 2025, an estimated $470K.
  • State Street first reported a position in Zomedica Corp. in Q2 2018 and held it in 19 quarters.
  • State Street's Zomedica Corp. position peaked at $15.3M in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.